Skip to content

The Feasibility of Pertussis Immunization in a Canadian Emergency Department

The Feasibility of Pertussis Immunization in a Canadian Emergency Department

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03304275
Enrollment
644
Registered
2017-10-06
Start date
2017-07-10
Completion date
2017-12-20
Last updated
2018-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis

Keywords

Pertussis, Vaccination, Emergency Department

Brief summary

Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine to patients presenting to the emergency department. Rates of vaccination as well as effects on department efficiency will be measured.

Detailed description

This study is a prospective randomized, controlled trial of two strategies to provide patients with the pertussis vaccine. Eligible adult patients with be offered pertussis vaccination in the Emergency Department vs. a referral to Public Health for pertussis vaccination. The effect of both strategies on triage time as well as measure of emergency department efficiency including length of stay, time to physician and left without being seen rates will be compared. At a four-month follow up, rates of pertussis vaccination will be measured.

Interventions

BEHAVIORALTdap

Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine

Sponsors

The Queen Elizabeth Hospital
CollaboratorOTHER
University of Prince Edward Island
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults age 18 and above * Have not received Tdap vaccine as an adult (age 18 and above) or have not received Tdap vaccine within 10 years, or unsure of vaccination status

Exclusion criteria

* Acute significant illness (Canadian Triage and Acuity Scale = 1) * Deemed in too much distress by triage nurse * Acute Febrile illness * Allergy to vaccine or vaccine components * Pts presenting for wound care (are normally given the vaccine as part of wound care) * Pregnancy \< 26 weeks

Design outcomes

Primary

MeasureTime frameDescription
Rate of immunizationOne dayRate of patients receiving Tdap vaccine

Secondary

MeasureTime frameDescription
Left with out being seen rateOne dayRate of patients leaving without being seen by a physician on study days.
Time to physicianOne dayTime to be seen by emergency physician after triage (mins, secs) on study days.
Patient refusalsOne dayReasons for patient vaccination refusal
Length of StayOne dayLength of Stay (mins, secs) for all patients presenting to the emergency. department on study days.
Additional vaccine receivedOne dayAdditional vaccines administered in the Public Health referral arm
Triage timeOne dayTime (in seconds) required to triage eligible patients in the emergency department
Nursing satisfactionOne dayFive statements rated on 5 point likert scale (strongly disagree (1) to strongly agree (5)). The immunization strategy significantly increased my workload; patient care was negatively affected by the immunization strategy; I was unable to provide the standard of care because of the immunization strategy; patient flow within the department was negatively affected by the immunization strategy; the ED should implement the immunization strategy

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026